Sage Therapeutics

ZULRESSO

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ZULRESSO – J1632

Manufacturer:

Sage Therapeutics

Name:

ZULRESSO

HCPCS Code Descriptor:

Injection, brexanolone, 1 mg

Category:

J Code

HCPCS:

J1632

NDC(s):

72152-0547-20

Primary Type:

Anti-Depressant

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ZULRESSO is an Anti-Depressant drug manufactured by Sage Therapeutics and administered via the Intravenous route of administration. The J Code: J1632 is aligned to the drug ZULRESSO.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

10/1/20

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Inj., brexanolone, 1 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.sagecentralsupport.com/zulressoforhealthcareproviders/